ArticleCell reports. Medicine2022

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.

Annika Fendler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.